Literature DB >> 2226797

Carbohydrate structures of a human tissue plasminogen activator variant expressed in recombinant Chinese hamster ovary cells.

M Nimtz1, G Noll, E P Pâques, H S Conradt.   

Abstract

The carbohydrate structures of a genetically engineered human tissue plasminogen activator variant bearing a single N-glycosylation site at Asn 448 are reported. After isolation of the tryptic glycopeptide and liberation of the N-linked carbohydrates by polypeptide:N-glycosidase F, 6 major oligosaccharide fractions were separated by HPLC on NH2-bonded phase. Their structures were determined by compositional and methylation analyses combined with fast atom bombardment mass spectrometry. Seventy percent of the carbohydrates were of the biantennary complex type with fucose at the proximal GlcNAc and zero, one or two alpha 2-3 linked NeuAc. The remainder were triantennary structures with one, two or three NeuAc.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226797     DOI: 10.1016/0014-5793(90)80361-l

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.

Authors:  I Björk; K Ylinenjärvi; S T Olson; P Hermentin; H S Conradt; G Zettlmeissl
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

2.  In vitro alpha1-3 or alpha1-4 fucosylation of type I and II oligosaccharides with secreted forms of recombinant human fucosyltransferases III and VI.

Authors:  M Nimtz; E Grabenhorst; U Gambert; J Costa; V Wray; M Morr; J Thiem; H S Conradt
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

3.  Deletion of new covalently linked cell wall glycoproteins alters the electrophoretic mobility of phosphorylated wall components of Saccharomyces cerevisiae.

Authors:  V Mrsa; M Ecker; S Strahl-Bolsinger; M Nimtz; L Lehle; W Tanner
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

4.  An HPLC-MALDI MS method for N-glycan analyses using smaller size samples: application to monitor glycan modulation by medium conditions.

Authors:  Michael P Gillmeister; Noboru Tomiya; Scott J Jacobia; Yuan C Lee; Stephen F Gorfien; Michael J Betenbaugh
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

5.  Construction and characterization of stably transfected BHK-21 cells with human-type sialylation characteristic.

Authors:  P Schlenke; E Grabenhorst; M Nimtz; H S Conradt
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.